Contract with Customer, Liability, Current of CRESCENT BIOPHARMA, INC. from 31 Dec 2024 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.
Summary
CRESCENT BIOPHARMA, INC. quarterly Contract with Customer, Liability, Current in USD history and change rate from 31 Dec 2024 to 31 Dec 2025.
  • CRESCENT BIOPHARMA, INC. Contract with Customer, Liability, Current for the quarter ending 31 Dec 2025 was $4,156,000.
Source SEC data
View on sec.gov
Contract with Customer, Liability, Current, Quarterly (USD)

CRESCENT BIOPHARMA, INC. Quarterly Contract with Customer, Liability, Current (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $4,156,000 +$4,156,000 31 Dec 2025 10-K 26 Feb 2026 2025 FY
Q4 2024 $0 31 Dec 2024 10-K 26 Feb 2026 2025 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.